Skip to content

HIV Pharmacology Workshop: Explaining tenofovir renal toxicities and interactions with protease inhibitors

HIV Pharmacology Workshop: Patch-testing to identify the genetic and clinical characteristics of abacavir hypersensitivity reaction - don’t try this at home

HIV Pharmacology Workshop: Explaining the genetic basis of AZT toxicity

Starting treatment with Kaletra involves greater risk of increased blood pressure, linked to gain in body mass

HIV infection, viral load and injecting drug use linked to early signs of cardiovascular disease

How frequently are ARV side-effects being seen in resource-limited settings, and how are they dealt with?

Growth hormone production reduced in HIV-positive men with fat redistribution

Steroid increases lean muscle mass in HIV-positive men, but has side-effects

Graves' disease may be a risk for patients starting ART with a low CD4 cell count who then have good immune restoratation